SalMar ASA (SALM)
Oslo Stock Exchange · Norway · prices in NOK · close of 22 Oct 2026
Key indicators
| Last close | NOK 578.00 |
|---|---|
| 52-week range | 448.00 – 627.00 |
| Return, 1 month / 3 months | +6.2% / +15.6% |
| Return, 1 year / 3 years | −2.2% / +28.7% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 29.0% |
| Worst drawdown (1 year) | -25.9% |
| Average daily value traded | 102.33M NOK |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SalMar ASA is a Norwegian aquaculture company that farms and sells Atlantic salmon. It operates sea-based fish farms along the Norwegian coast and also runs processing and sales operations that turn harvested fish into fresh and frozen salmon products. Its customers are seafood buyers, distributors and food companies in Norway and in export markets abroad. The company is based in Frøya, in central Norway, where its farming and processing activities are rooted.
SalMar ASA trades under the code SALM on the Oslo Stock Exchange in Norway, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SalMar ASA (SALM) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 578.00 on 22 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 72 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.2% and over the last three months it rose 15.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 6.5% | ||
| From 52-week high | -7.1% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 15.6% | ||
| 6-month return | 9.3% | ||
| 12-month return, skipping the last month | -7.9% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.9% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 102.33M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.9% |
|---|---|
| 1 month | +6.2% |
| 3 months | +15.6% |
| 6 months | +9.3% |
| 1 year | −2.2% |
| 3 years | +28.7% |
| 5 years | +10.1% |
Signals
| 50-day / 200-day average | 556.70 / 542.71 |
|---|---|
| Golden / death cross (60 days) | Golden, 14 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 14.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Jun 2026 | NOK 10.0000 |
| 19 Jun 2025 | NOK 22.0000 |
| 7 Jun 2024 | NOK 35.0000 |
| 9 Jun 2023 | NOK 20.0000 |
| 9 Jun 2022 | NOK 20.0000 |
| 9 Jun 2021 | NOK 20.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.